Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in GALT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.0M | $13.9M | +273.9% | 4.538% | 0.00% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $10.1M | +10.3% | 3.292% | 0.00% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $6.1M | +113.5% | 1.987% | 0.00% |
| 4 | OSAIC HOLDINGS, INC. | 1.2M | $5.6M | +7.2% | 1.828% | 0.01% |
| 5 | MARSHALL WACE, LLP | 831K | $3.9M | -31.9% | 1.262% | 0.00% |
| 6 | GREAT POINT PARTNERS LLC | 800K | $3.7M | 0.0% | 1.215% | 0.70% |
| 7 | Wealthspire Advisors, LLC | 722K | $3.3M | 0.0% | 1.096% | 0.02% |
| 8 | STATE STREET CORP | 568K | $2.6M | +119.7% | 0.862% | 0.00% |
| 9 | CITADEL ADVISORS LLC | 539K | $2.5M | +48.3% | 0.818% | 0.00% |
| 10 | COMMONWEALTH EQUITY SERVICES, LLC | 407K | $1.9M | +10.9% | 0.618% | 0.00% |
| 11 | NORTHERN TRUST CORP | 387K | $1.8M | +196.3% | 0.587% | 0.00% |
| 12 | VANGUARD FIDUCIARY TRUST CO | 366K | $1.7M | +20.5% | 0.556% | 0.00% |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 328K | $1.5M | -69.4% | 0.498% | 0.00% |
| 14 | VANGUARD PORTFOLIO MANAGEMENT LLC | 328K | $1.5M | — | 0.498% | 0.00% |
| 15 | TWO SIGMA INVESTMENTS, LP | 318K | $1.5M | -31.9% | 0.483% | 0.00% |
| 16 | LPL Financial LLC | 285K | $1.3M | +6.8% | 0.433% | 0.00% |
| 17 | Geneos Wealth Management Inc. | 240K | $1.1M | -0.2% | 0.365% | 0.02% |
| 18 | UBS Group AG | 219K | $1.0M | +22.0% | 0.333% | 0.00% |
| 19 | RETIREMENT GUYS FORMULA LLC | 211K | $979K | +12.8% | 0.321% | 0.37% |
| 20 | Sovran Advisors, LLC | 258K | $875K | +0.1% | 0.392% | 0.07% |
| 21 | NATIONAL BANK OF CANADA /FI/ | 168K | $779K | — | 0.255% | 0.00% |
| 22 | BLAIR WILLIAM & CO/IL | 149K | $693K | 0.0% | 0.227% | 0.00% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 116K | $540K | +288.0% | 0.177% | 0.00% |
| 24 | Bank of New York Mellon Corp | 106K | $491K | — | 0.161% | 0.00% |
| 25 | HighTower Advisors, LLC | 94K | $437K | +0.8% | 0.143% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in GALT — a direct measure of their conviction.
Filings activity in GALT during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new GALT position in Q2 2026
Institutions that fully closed their GALT position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +1.0% | 25.81% | +2.16 pp | $77M | +82% |
| Q1 2026 | 100 | +4.2% | 23.65% | +4.20 pp | $42M | 15% |
| Q4 2025 | 96 | +14% | 19.45% | +3.07 pp | $50M | +19% |
| Q3 2025 | 84 | +0.0% | 16.38% | +0.05 pp | $42M | +112% |
| Q2 2025 | 84 | 8.7% | 16.33% | 0.24 pp | $20M | +63% |
| Q1 2025 | 92 | +0.0% | 16.57% | 2.47 pp | $12M | 27% |
| Q4 2024 | 92 | +15% | 19.04% | +2.79 pp | $17M | 36% |
| Q3 2024 | 80 | — | 16.25% | — | $26M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Metabolic & Cardiovascular Biotech peers.
| Ticker | Company | Market Cap | Inst. Ownership | Holders | Net Buyers − Sellers |
|---|---|---|---|---|---|
| EOCN | Eocene Ltd. | $3M | 1.3% | 14 | -3 |
Quick answers to the most common questions about buying GALT stock.
Based on Q2 2026 13F filings, institutional ownership of Galectin Therapeutics Inc. stands at 25.8%, held across 101 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of GALT, with approximately 2,988,353 shares worth $0.01B as of Q2 2026.
Yes — 3 widely-followed marquee investors appear among the top 25 institutional holders of GALT, including CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for GALT is 71 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
19 institutions opened new positions in GALT during Q2 2026, while 18 fully exited. 70 added to existing positions and 8 trimmed.
GALT institutional ownership rose by 2.16 percentage points quarter-over-quarter, with a net change of +1 holders.
The top 10 institutions account for 69.4% of all reported 13F value in GALT, and the top 25 account for 90.5%.
Across the largest Metabolic & Cardiovascular Biotech peers, institutional ownership levels are: EOCN (1.3%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.